Martin J Driscoll - Net Worth and Insider Trading
Martin J Driscoll Net Worth
The estimated net worth of Martin J Driscoll is at least $229,540 dollars as of 2024-04-27. Martin J Driscoll is the President and CEO of Spring Bank Pharmaceuticals Inc and owns about 47,425 shares of Spring Bank Pharmaceuticals Inc (SBPH) stock worth over $229,537. Martin J Driscoll is also the Director of MetaStat Inc and owns about 29,616 shares of MetaStat Inc (MTST) stock worth over $3. Details can be seen in Martin J Driscoll's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martin J Driscoll has not made any transactions after 2020-11-20 and currently still holds the listed stock(s).
Transaction Summary of Martin J Driscoll
Martin J Driscoll Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin J Driscoll owns 3 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , MetaStat Inc (MTST) , and F-star Therapeutics Inc (FSTX) .
Click here to see the complete history of Martin J Driscoll’s form 4 insider trades.
Insider Ownership Summary of Martin J Driscoll
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-11-20 | director & President and CEO |
| MTST | MetaStat Inc | 2017-04-04 | director |
| FSTX | F-star Therapeutics Inc | 2016-05-05 | director & President and CEO |
Martin J Driscoll Latest Holdings Summary
Martin J Driscoll currently owns a total of 2 stocks. Among these stocks, Martin J Driscoll owns 47,425 shares of Spring Bank Pharmaceuticals Inc (SBPH) as of November 20, 2020, with a value of $229,537 and a weighting of 100%. Martin J Driscoll also owns 29,616 shares of MetaStat Inc (MTST) as of October 30, 2016, with a value of $3 and a weighting of 0%.
Latest Holdings of Martin J Driscoll
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-11-20 | 47,425 | 4.84 | 229,537 |
| MTST | MetaStat Inc | 2016-10-30 | 29,616 | 0.00 | 3 |
Holding Weightings of Martin J Driscoll
Martin J Driscoll Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin J Driscoll has made a total of 5 transactions in Spring Bank Pharmaceuticals Inc (SBPH) over the past 5 years, including 4 buys and 1 sells. The most-recent trade in Spring Bank Pharmaceuticals Inc is the sale of 175 shares on November 20, 2020, which brought Martin J Driscoll around $833.
According to the SEC Form 4 filings, Martin J Driscoll has made a total of 0 transactions in MetaStat Inc (MTST) over the past 5 years. The most-recent trade in MetaStat Inc is the acquisition of 28,342 shares on October 30, 2016, which cost Martin J Driscoll around $56,684.
Insider Trading History of Martin J Driscoll
- 1
Martin J Driscoll Trading Performance
GuruFocus tracks the stock performance after each of Martin J Driscoll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin J Driscoll is -12.03%. GuruFocus also compares Martin J Driscoll's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin J Driscoll within 3 months outperforms 5 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin J Driscoll's insider trading performs compared to the benchmark.
Performance of Martin J Driscoll
Average Return
-0.78%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.48 | -12.03 | -6.99 | -0.78 | -12.15 | -34.94 |
| Relative Return to S&P 500(%) | -1.17 | -15.06 | -13.87 | -13.52 | -23.93 | -45.79 |
Martin J Driscoll Ownership Network
Ownership Network List of Martin J Driscoll
Ownership Network Relation of Martin J Driscoll
Martin J Driscoll Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Martin J Driscoll is the director & President and CEO of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , Chief Scientific Officer Radhakrishnan P. Iyer , and General Counsel and Secretary Garrett Winslow .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Martin J Driscoll Mailing Address
Above is the net worth, insider trading, and ownership report for Martin J Driscoll. You might contact Martin J Driscoll via mailing address: C/o Javelin Pharmaceuticals, Inc., 125 Cambridge Park Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
